P - ISSN : 2349-6592    |    E - ISSN : 2455-7099
Year : 2014 | Volume : 1 | Issue : 4 | Page : 229-235
Source of Funding:None Conflict of Interest:None
Title- Alterations of thyroid function in critically ill children Aims & Objective- To study thyroid hormonal changes in critically ill children and correlate them with outcome. Methods-In this prospective study total serum T3, T4and TSH levels were estimated at admission and at discharge or prior to death in fiftycritically ill cases admitted to PICU.Fifty healthy children were taken as controls. PRISMII score was used to predict outcome. Hormone levels were compared between cases and control and then between survivors and non survivors. Results-Mean T3 (59.86±16.09 vs123.04±26.21)and T4 levels (5.38±1.30vs8.70±1.82) in cases were significantly (P-0.000) lower than that of controls,however no significant difference in the mean TSH values (2.21±1.91 vs2.18±1.06) were noted. Fourteen (28%) cases expired. Admission T3 level (44.71±13.35 Vs65.75±13.01) was significantly (p-0.000) lower in non survivors than survivors but there was no significant difference in T4 (4.86±1.57Vs5.57±1.15) and TSH(2.17±1.69 Vs 2.28±2.12 ) levels. Serum T3 (65.75±13.01vs96.36 ±25.48),T4 (5.57±1.15vs8.52±3.19) and TSH levels(2.28±2.12 vs3.06±1.61)improved in survivors butfailed to improve innon survivors. LowT3 and T4 at admission were associated with high risk of mortality (odds ratio 14.8, p-0.000). PRISMII score and T4 in second sample were significant predictors of death. Conclusion- In critically ill children T3, T4 levels are low, while TSH values may not change. T3 levels reflect patient’s clinical status and T4 levels can predict death. Key words- thyroid hormone, critically ill children, PRISMII
Altered thyroid function in nonthyroidalillness(NTI) is a well-recognized finding.(1,2)The term euthyroid sick syndrome (ESS) identifies abnormalities in thyroid function tests observed in patients with systemic nonthyroidal illnesses (NTIs).ESS has been classified as Type 1- low T3 syndrome, Type 2-low T3&low T4 syndrome and Type 3-low TSH syndrome. The severity and the nature of changes in thyroid function test have implications for the prognosis of the systemic illness.(3,4)These abnormalities result from variable, usually reversible, disturbances in the hypothalamo-pituitary-thyroid axis, thyroid hormone binding to serum proteins, tissue uptake of thyroid hormones, and/or thyroid hormone metabolism.(5)
The production of thyroxine (T4) by the thyroid gland is regulated by the classic hypothalamus-pituitarythyroid axis, in which the anterior pituitary releases thyroid stimulating hormone (TSH) thyrotropin as a result of the stimulation by hypothalamic thyrotropinreleasing hormone (TRH). The biological activity of thyroid hormone (i.e. the availability of the active hormone 3,5,3 V-triiodothyronine [T3]), is largely regulated by the iodothyroninedeiodinases D1, D2, and D3 which convert T4 to either T3 or to the inactive metabolite reverse T3 (rT3). Both T4 and T3 have an inhibitory effect on TRH and TSH secretion by way of a negative feedback loop mechanism.(5,6)
Low serum total T3 is the most common abnormality in NTI. It is observed in about 70% of hospitalized patients.(7) Serum total T3 may vary from undetectable to normal in patients with systemic illness.Within a few hours after the onset of disease, plasma T3 decreases and plasma rT3 increases, and the magnitude of these reciprocal changes is related to the severity of the disease.(7-9)Altered expression of thyroid hormone transporters, impairment of 5’ deiodinaseactivity due to reduced availability of the enzyme co-factorglutathione due to reduced intake of carbohydrates, stress induced elevated steroids and free fatty acids as inhibitor of extra-thyroidal T4 to T3 conversion are some of the postulated mechanisms. (10-13)
T4 decreases as well with T3 in severely ill patientsand both low T4 and low T3 are associated with a poorprognosis.(14-16) Suppression of thyroid releasing hormone (TRH) from hypothalamus due todysregulation or inhibitory action of somatostatin,decreased pituitary response to TRH,decreased pituitary secretion of TSH due to cortisol, growth hormone, dopamine, opiate peptides secreted in response to stress, decreasedresponsiveness of pituitary TSH to low T3 or T4 and reduced plasmabinding of T4 are suggested reasons for low T4.(17-20)
Majority of the studies till date on thyroid function test and its correlation with outcome in critically ill patients are mainly conducted in surgical ICUs especially in adults. There is paucity of data available in pediatrics ICUs, especially in India on this subject. Hence present study was conducted to evaluate the alteration of thyroid hormone function in critically ill children and to assess its correlation with their outcome.
Materials and Methods
In this prospective study fiftycritically ill children admitted in Pediatric intensive care unit (PICU) were studied over a period of 1.5years (august 2010 to february2012). Critical illness was defined as any condition leading to malfunction of one or more organ system requiring support to maintain vital functions either with mechanical or pharmacological aids. PRISMII score (Pediatric risk of mortality score) was used to predict the outcome in critically ill patients at 0 and 24 hours. Data was collectedwithin first hour of admission to pediatric ICU. Data collection pertinent to the analysis included ICU admission diagnosis, categorized by primary physiologic instability and outcome (survival or death). Total serum T3,T4,TSH levels were estimated twice in critically ill patients,first sample at admission to PICU and second sample at discharge or prior to death (depending on the outcome ofpatient).Fifty age and sex matched healthy children were taken as controls.
Admissions for post procedure recovery, cases with maternal or family history of thyroid illness,clinical evidence of thyroid dysfunction, or patients on any thyroid medication or on long term glucocorticoids, patient on drugslike radiographic agents,amidarone and propranolol which affect directly thyroid functionwere also excluded from the study. The data was recorded on standardized sheet and included demographic variables such as age, sex, outcome, T3, T4, TSH levels and 14 physiological variables used in PRISMII score.Estimation of variable parameters was done. Blood pressure was recorded withnoninvasive multipara monitors and oxygen saturation measured with pulse oximeter at admission. The Fio2 required formaintaining oxygen saturation above 90% was noted with oxygen monitor. Radial artery sampling was used for determining Pao2, Paco2 and bicarbonate levels. Standard lab techniques were utilized to measure blood levels of total bilirubin, protein,potassium, calcium, glucose, prothrombin time and partial thromboplastin time. Clinical assessment of heart rate, respiratory rate and pupillary reaction for each patient was made. The children were followed up during the hospital stay and the outcome measures were recorded as deathor survived at the end of hospital stay.Serum total T3, T4 & TSH levels were estimated by solid-phase competitive luminescence immunoassay (CLIA). T3 values less than 60 ng/dl, T4 values less than 4.5 mcg/dl & TSH values less than 0.3 uU/ml was considered as lowT3, T4 & TSH values respectively. Cases were also classified as Type I, Type II & Type III Euthyroid sick syndrome (ESS) accordingly. Only low T3 as ESS Type I, both Low T3 & Low T4 as ESS Type II & Low TSH as ESS Type III.
The hospital ethics and review board’s approval and informed consent from relatives was taken before undertaking the study. Statistical analysis of data was done by using IBM SPSS 19.0 Statistics software. Normally distributed continuous variables were compared with Student’s t-test and categorical variables were compared with Chi-square test or Fisher’s exact test. Pearson Correlation coefficient was used to study bivariate correlation. After determination of individual factors with mortality by univariate analysis, a binary logistic regression model of significant factors associated with mortality was developed. The results of regression model were presented as adjusted odds ratio. Wald’s chi square value was used to test unique contribution of each predictor. Regression model adequacy was tested by Omnibus test of model coefficients, Negelkerke R square and Hosmer&Lameshow chi square test. Receiver Operating Characteristic Curve analysis was used to find out the cut-off values for T, T4 and TSH and for PRISM II score to validate predicted probabilities of death.P< 0.05 was considered statistically significant.
Mean age of fifty critically ill children inthe case group was78.92±40.78 months (range14 to 156 months).There was no significant difference in mean values of T3(60.28± 17.69 Vs.57.12 ±12.71ng/ dl), T4(5.64±1.05 Vs. 5.41±1.25mcg/dl) and TSH (2.53±1.25Vs2.24±1.61) between males and females. The distribution of cases according to diagnosis is mentioned in Table 2.Mean total protein levels (5.49±1.67 vs.6.01±0.66 gm) were comparable between cases & controls. Fourteen (28%) children died and 36 (72%) survived. The means and SD of thyroid profile for given sample size and alpha (0.05,2 tailed), power of study was 1.00. The average duration between the first and second sample in survivors was 7.64 ± 2.08 days and in non survivorscases was 6.29 ± 2.28 days.
Mean serum T3 and serum T4 levels were significantly lower in cases than that in controls. Howeverserum TSH levels were not significantly different betweentwo groups (Table 1). At admission there was no significant difference in the serum levels of T4 and TSH between survivor and non survivors. However serum T3 level was significantly lower in non survivors (Table 3). Among survivors T3, T4 and TSH levelsat discharge showed significant (p-0.000) rise as compared to their admission levels. However T3, T4 and TSH levelsin the non survivors failed to improve (Table 4). There was no significant difference inmean total protein levels (5.78±0.62 Vs 5.38±0.66) between survived and expired children.
Low T3 alone (type I ESS) was seen in 32 (64%) children, mortality in this group was 37.5% (12 out of 32) (odds ratio 4.1,p=0.056) while a combination of low T3 and T4 (type II ESS) was seen in 13 (26%) cases with mortalityof 69.23% (9 out of 13) in this group and demonstrated almost 15 times more risk of mortality (odds ratio 14.9, p<0.000). Only 3 (6%) cases had isolated low TSH (typeIII ESS) & 2 (4%) had lowT4 alone. There was no death inType III ESS group.
PRISMII score at 24 hrs.was significantly higher in patients who expired (10.79±1.72 Vs 7.50±1.75,p= 0.000). PRISM score at 24 hours did not correlate with T3, T4 or TSH levels at admission, but had negative correlation with T4 levels of the second sample (Table 5). Age, sex, duration of PICU stay, ventilation and inotropic support did not show any correlation with patient outcome or thyroid hormone profile.
The area under Receiver Operator Characteristic (ROC) curve for the various thyroid hormone parameters, PRISMII score at admission and 24 hrs. with death as classification variable, along with the sensitivity and specificity is listed in table 7. The values for Area under curve (AUC) for second T4 (0.932) was comparable for PRISMII score (0.907) [Table 7] [Fig 1]. As AUC for second T4 for had highest sensitivity & specificity closely matching with respective value of PRISMII score, T4 as an
independent risk factor for mortality was studied by multivariate analysis using forward stepwise method of binary logistic regression. PRISM score at 24 hrs. And T4 levels in second sample were found to be significant predictors of mortality; (Table 6). Values of Omnibus model coefficient(33.58.p-0.000 at df=2) Nagelkerke R square (0.704) and Hosmer & Lemeshow test (chi-square 9.11 at df-8, sig.0.333) indicated strong predictive value & overall fitness of the regression model. Other thyroid hormone parameters were not found to predict mortality significantly.
Present study demonstrated lowermean T3 and T4 levels in the critically ill children. The commonest change seen was reduced serum T3 level (64% of cases). Low T4 levels were seen in 30% of cases,while low serum TSH level in only 6%of cases. Similar pattern was observed by Suvarna et al.(25) Many studiesreported ahigher incidence of lowT3 levels in critically ill patients(14,22,24,25)but Bermudez et al(7) in their study on adult patients and Anand et al(21) in their study on critically ill infants failed to demonstrate significant lower serum T4 levels.
The combination of low T3 & low T4 was associated with almost 15 times risk of mortality in the present study. Similar observation was demonstrated in Zargar et al & Suvarna et al. (14,25)However, further multi-centric studies with larger sample size may throw more light on this aspect.
The serum T3 levels at admission has been considered as baseline discriminator between survivors and non-survivors, which can prognosticate the clinical status ofcritically ill patients.(15)In the present study the mean serum T3 levels at admission was lower in nonsurvivors. Though Zucker et al & Suvarna et al (24,25) had similar observation, Anand et al & Uzel et al failed to demonstrate the same in infants.(21,22) It was also noted that serum T3 level improved in patients discharged from the PICU and did not improve in those who expired. This implies that serum T3 level closely follows the clinical status of the patients and persistently lowserum T3 level may reflect poor outcome.
Although serum T4 level at admission did not discriminate between survivors and non-survivors, it decreased in patients prior to death reflecting the seriousness of the disease. It is postulated that when an illness is severe but less than life threatening, T4 levels are maintained due to increased secretion rate to match the accelerated T4 disposal. However, in very severe illness, the T4 level fails to keep up pace with the accelerated turnover and decreases. (17) Wecould not demonstrate any cut-off value for T4 to correlatewith patient’s outcome. Zucker et al too failed to show this relationship.(24) Serum T4 levels at discharge from PICU or just prior to death and PRISMII score at 24 hours of admission to the PICU were found to besignificant predictorsof mortalitywith highest sensitivity & specificity. Similar finding was observed bySuvarna et al.(25)
Type II ESSis reported with more severe illness and indicates a very poor prognosis.(15,16) In 26 % cases it demonstrated almost 15 times increased risk of mortality. Suvarna et al(25)reported 30 times risk of mortality in such patients.Thesepatients have inappropriately normal or low TSH inspite of low T3 and T4 and are considered to be clinically euthyroid. Glutathione and selenium are postulated to be co-factors for both enzymes: deiodinase (needed for T4 to T3 conversion) and glutathione peroxidase (defense strategy of the body to combat oxidative stress). Stress (critical illness) decreases the activity of deiodinase, thus sparing the co-factors for glutathione peroxidase activity (to combat stress). (3)Also low T3 decreases catabolism, thus decreasing mitochondrial free radical generation, and allowing energy to be expended for the defense processes. Thus ESS maybe considered as an adaptive process. (7,8,24,29)
We observed that in patients who survived, TSH levels increased significantly while it failed to improve in patients who expired. Similar observation was found by Suvarna et al.(25)The transient increase in serum TSH during recovery from NTI suggests that TSH is suppressed in an illness. Pituitary TSH suppression may be related to the stress of an illness, and the resulting elevated cortisol and catecholamine levels and associated caloric deprivation.(4)
Almost in all critical illness,there is a decreasein plasma concentration of proteins that bind thyroid hormone [albumin, thyroid binding pre albumin (TBPA) & thyroid binding globulin (TBG)]. As binding proteinsdecrease, total levels of T4 and to lesser degree of T3 decline.(1,3,5) The free thyroxine index (FT4I) is an estimate of the amount of circulating free thyroxine which doesn’t get affected by levels of TBG or TBPA and can be used as sensitive indicator to diagnose ESS.(2,3,6)We have not estimated FT4I ,TBPA or TBG in our study due to high cost involved, butas there was no significant difference in total serum protein levels of either cases and controls or between survived and expired, we can presume that changes in thyroid profile were reflecting critical phase of illness and not hypoproteinemia.
‘Is there any role of T3, T4 supplementation in critically ill patients inimproving survival?’ The improvement of T3 levels in patients who survived and non-improvement in those who expired raises this important question, Most studies perceive low T3 without increased TSH as an adaptive response (metabolically protective) not warranting administration of T3 or T4 in NTI.(20,23,24,28) Moreover decreased deiodinase activity in NTI may hamper peripheral conversion of T4 to T3.(28) T4 therapy may in fact suppress thyroid function normalization during recovery by inhibiting TSH secretion.(28) Administration of T3 in severe burnsdid not affect survival.(17) However T3 infusion in patients with septic shock showed elevation of systolic blood pressure, reduced vasopressor requirement and improvement in renal function.(28) Recent reports showed cardiac surgery patients with ESS tolerated T3 replacement therapy well and showed hemodynamic improvementsin form of increase in cardiac index, reduced need of for inotropic agents and mechanical device and decreased incidence of myocardial ischemia(27) The therapeutic role of thyroid hormones in the management of NTI is still not very clear and awaits further well controlled randomized trials.
In critically ill children,mean T3, T4 levels are low,while TSH values may not change. At any given point T3 level reflects the patient’s clinical status and persistent low serum T3 levels with nonimprovement would predictbad prognosis. Low T3 & T4 values at admission are associated with very high risk of mortality. T4 levels independently can predict mortality with high sensitivity & high specificity like PRISMIIscore at 24 hours. Children with combined low T3 and T4 levels need more close observation and aggressivetherapeutic intervention.
Confounding bias related to effect of inotropic agents (dopamine, dobutamine) or exogenous steroid used in critical illness on thyroid hormones could not be eliminated. Estimation of rT3 and free T4 was not done in this study which would have given us an additional thyroid indicator of prognostic value.The thyroid hormone profile was done only twice i.e. at admission and at recovery or death in this study. More frequent estimation to assess the trend of changes in the thyroid hormone profile in the sick children can give us better information and help us to identify seriously ill patients much earlier.
Dr NathanealSase, Director, Wanless Hospital, Miraj
1. Peeters RP, Debaveye Y, Fliers E, Visser TJ. Changes within the thyroid axis during critical illness. Crit care clin 2006; 22:41-55.
2. Peeters RP, Geyten S, Wouters PJ, Darras VM, Toor H et al. Tissue thyroid hormone in critical illness. J ClinEndocrinolMetab 2005; 90: 6498-6507
3. Bayarri VM, Sancho S, Campos C, Faus R, Simon JM, Porcar E et al.Theeuthyroid sick syndrome in severe acute illness.Presse Med 2007; 36: 1550-1556.
4. Chopra IJ. Euthyroid sick syndrome:Is it a misnomer? JClinEndocrinolMetab1997;82:329-334.
5. Chopra IJ, Hershman JM, Pardridge WM, NicoloffJT. Thyroid function in nonthyroidal illness. Ann Intern Med 1983; 98: 946-957.
6. Peeters RP, Wouters PJ, Kaptein E, Toor H, Visser TJ et al. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J ClinEndocrinol Metab 2003; 88: 3202-11
7. Bermudez F, Surks MI, Oppenheimer JH. High incidence of decreased serum triiodothyronine concentration in patients with non-thyroidal disease. J ClinEndocrinol Metab 1975; 41:27-40.
8. Chopra IJ, Chopra U, Smith SR, Reza M, Solomon DH.Reciprocal changes in serum concentrations of 3, 3, 5-triiodothyronine (T3) in systemic illness. J ClinEndocrinol Metab1975; 41: 1043-1049.
9. Huang SA, BiancoAC. Reawakened interest in type III iodothyroninedeiodinase in critical illness and injury. NatClinPractEndocrinol Metab. 2008; 4(3): 148–155.
10. MebisL, Paletta D, Debaveye Y, Ellger B, Langouche L et al. Expression of thyroid hormone transporters during critical illness. Eur J Endocrinol2009; 161: 243-250.
11. Sahana PK, Ghosh A, Mukhopadhyay P, Pandit K, Chowdhury BK, Chowdhury S. A study on endocrine changes in patients in intensive care unit. J Indian Med Assoc2008; 106: 362-364.
12. Gamstedt A, Jarnerot G, Kagedal B, Soderholm B. Corticosteroids and thyroid function. Acta Med Scand 1979; 205: 379-383
13. Chopra IJ, Huang T, Beredo A et al. Evidence for an inhibitor of extrathyroidalconversión of thyroxine to 3,5,3’- triiodothyronine in sera of patients with nonthyroidal illness. J ClinEndocrinolMetab1985; 60: 666-672.
14. Zargar AH, Ganie MA, Masoodi SR, Laway BA, Bashir MI et al. Prevalence and pattern of sick euthyroid syndrome in acute and chronic non-thyroidal illness- Its relationship with severity and outcome of the disorder. JAPI 2004; 52:27-31
15. Kaptein EM, Weiner JM, Robinson WJ, Wheeler WS, Nicoloff JT. Relationship of altered thyroid hormone indices to survival in non-thyroidal illness. ClinEndocrinol 1982; 16: 565-574
16. Slag MF, Morley JE, Elson MK, Crowson TW, Nuttall FQ, Shafer RB. Hypothyroxinemia in critically ill patients as a predictor of high mortality. J Am Med Assoc1981; 245: 43- 45
17. Wehmann RE, Gregerman RI, Burns WH, Saral R, Santos GW.Suppression of thyrotropin in the low thyroxine state severe nonthyroidalillness. NEngl J Med 1985; 312: 546-552.
18. Sumita S, Ujike Y, Namiki A et al. Suppression of the thyrotropin response to thyrotropin releasing hormone and its association with the severity of critical illness. CritCareMed1994; 10: 870-875.
19. Romijn JA, Wiersinga WM. Decreased nocturnal surge of thyrotropin in nonthyroidal illness. J ClinEndocrinolMetab 1990; 70: 35-42.
20. Kaptein EM, Grieb DA, Spencer CA, Wheeler WS, Nicoloff JT. Thyroxine metabolism in the low thyroxine state of critical nonthyroidal illness. J ClinEndocrinol Metab 1981; 53:764-770.
21. Anand NK, Chandra V, Sinha RSK, Chellani H. Evaluation of thyroid functions in critically ill infants. Indian Pediatr 1993; 31: 1233-1237.
22. Uzel N, Neyzi O. Thyroid function in critically ill infants with infection. Pediatr Infect Dis 1986; 5: 516-519.
23. Lim DJ, Herring MK, Leef KH, Getchell J, Bartoshesky LE, Paul DA. Hypothyroxinemia in mechanically ventilated term infants is associated with increased use of rescue therapy. Pediatrics 2005; 115: 406-410
24. Zucker AR, Chernow B, Fields AI, Hung W, BurmanKD. Thyroid function in critically ill children. J.Pediatrics 1985; 107: 552-554.
25. SuvarnaJC,FandeCN.Serum thyroid hormone profile in critically ill children. Indian J Pediatr 2009; 76(12): 1217- 1221.574.
26. Vasa FR, Molitch ME. Endocrine problems in the chronically ill patient.Clin Chest Med 2001; 22: 193-208.
27. Haas NA, Camphausen CK, Kececioglu D. Clinical review: Thyroid hormone replacement in children after cardiac surgery: is it worth a try? Crit Care 2006; 10: 213.
28. Brent GA, Hershman JM. Thyroxine therapy in patients with severe non thyroid illnesses and low serum thyroxineconcentration. J ClinEndocrinolMetabol 1986; 63: 1-8.
29. Cartner JN, Eastman CJ, Corcoran JM, Lazarus L. Effect of severe, chronic illness on thyroid function.Lancet1974; 26:971-974.